Cleared Traditional

K112897 - RENOVIS SURGICAL HIP JOINT REPLACEMENT ...

K112897 is an FDA 510(k) clearance for RENOVIS SURGICAL HIP JOINT REPLACEMENT ..., manufactured by Renovis Surgical Technologies, LLC. The device is a Class 2 Orthopedic device with product code OQG cleared through the Traditional 510(k) pathway after a 254-day FDA review.

K112897 · Renovis Surgical Technologies, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
254d
Days
Class 2
Risk

K112897 is an FDA 510(k) clearance for the RENOVIS SURGICAL HIP JOINT REPLACEMENT PROSTHESIS. Classified as Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented (product code OQG), Class II - Special Controls.

Submitted by Renovis Surgical Technologies, LLC (Minneapolis, US). The FDA issued a Cleared decision on June 13, 2012 after a review of 254 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Renovis Surgical Technologies, LLC devices

FDA 510(k) Submission Details - K112897

510(k) Number K112897 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 2011
Decision Date June 13, 2012
Days to Decision 254 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 122d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OQG Device Classification - Class 2, Special Controls

Product Code OQG Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
Definition 1. Non-inflammatory Degenerative Joint Disease Including Osteoarthritis And Avascular Necrosis. 2. Rheumatoid Arthritis. 3. Correction Of Functional Deformity. 4. Treatment Of Non-union, Femoral Neck Fracture, And Trochanteric Fractures Of The Proximal Femur With Head Involvement, Unmanageable By Other Techniques. 5. Revision Procedures Where Other Treatment Or Devices Have Failed. Cemented And Uncemented Use.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - OQG Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented

All 13
Devices cleared under the same product code (OQG) and FDA review panel - the closest regulatory comparables to K112897.
PLASMAFIT ACETABULAR CUP AND VITELENE INSERT
K122783 · Aesculap Implant System, Inc. · Oct 2013
X-ALT HIGHLY CROSS LINKED VE ACETABULAR LINER
K130365 · Encore Medical, L.P. · Sep 2013
CROSS-OVER ACETABULAR SHELL & LINER
K122773 · Stelkast Company · Oct 2012
VIVACIT-E VITAMIN E HIGHLY CROSSLINKED POLYETHYLENE LINERS
K120370 · Zimmer, Inc. · Jun 2012
EXP ACETABULAR LINER, MODELS SC3342 NON-HOODED 28MM, SC3343 HOODED 28MM
K094035 · Stelkast Company · Mar 2011